4 free views remaining today
3-M syndrome
ICD-10 Codes
Description
What is 3-M Syndrome?
3-M syndrome, also known as primordial dwarfism, is a rare genetic disorder that affects growth and development in individuals. It is characterized by severe growth retardation, distinctive facial dysmorphic features, and skeletal abnormalities.
Key Features:
- Short Stature: Individuals with 3-M syndrome grow extremely slowly before birth (intrauterine growth restriction) and after birth, resulting in short stature (dwarfism).
- Unusual Facial Features: Characteristic facial features include a triangular face shape, pointed chin, large ears, and other distinctive facial dysmorphia.
- Skeletal Abnormalities: Skeletal abnormalities are common, including short broad neck, prominent trapezii, deformed sternum, short thorax, square shoulders, winged scapulae, hyperlordosis, short fifth fingers, prominent heels, and others.
Genetic Cause:
3-M syndrome is caused by mutations in one of three genes: CUL7, OBSL1, and CCDC8. These genetic changes lead to growth failure and other characteristic features of the disorder.
References:
- [12] describes 3-M syndrome as a disorder that causes skeletal abnormalities including short stature (dwarfism) and unusual facial features.
- [13] mentions that individuals with 3-M syndrome have a recognisable pattern of features, including a triangular face shape with pointed chin, large ears, and other distinctive facial dysmorphia.
- [14] states that pathogenic variants in three different genes are known to cause 3M syndrome, with CUL7 being the most common gene involved.
Note: The information provided is based on the search results within the context.
Additional Characteristics
- Skeletal abnormalities
- Triangular face shape
- A rare genetic disorder
- Unusual facial features
- Severe growth retardation
- Distinctive facial dysmorphic features
- Short stature (dwarfism)
- Pointed chin
- Large ears
- Mutations in CUL7, OBSL1, or CCDC8 genes
Signs and Symptoms
Common Signs and Symptoms of 3-M Syndrome
3-M syndrome, also known as 3M syndrome or Three M syndrome, is a rare genetic disorder characterized by several distinct signs and symptoms.
- Low birth weight: Individuals with 3-M syndrome are often born with low birth weight, which can be an early indicator of the condition [7].
- Short stature (dwarfism): One of the most common signs of 3-M syndrome is short stature or dwarfism. This is due to severe growth retardation, which affects both prenatal and postnatal development [4, 5, 9].
- Unusual facial features: Individuals with 3-M syndrome often have distinctive facial features, including a triangular face shape, flat maxillae, and a prominent forehead [6]. These facial characteristics can be a key indicator of the condition.
- Skeletal abnormalities: 3-M syndrome is also associated with various skeletal abnormalities, such as tall vertebrae, short limbs, and other radiological irregularities [6].
- Severe prenatal and postnatal growth retardation: Individuals with 3-M syndrome often experience severe growth restriction both before and after birth, which can lead to short stature and other developmental issues [4, 8].
These signs and symptoms are typically present from birth or early childhood and can vary in severity among affected individuals.
Additional Symptoms
- Skeletal abnormalities
- Unusual facial features
- Severe prenatal and postnatal growth retardation
- low birth weight
- short stature
Diagnostic Tests
Diagnostic Tests for 3-M Syndrome
Diagnosing 3-M syndrome involves a combination of clinical evaluation and genetic testing.
- Clinical Features: The presence of characteristic abnormalities, such as low birth weight, short stature (dwarfism), and unusual facial features, is the primary basis for diagnosis [1][2].
- Genetic Testing: Confirmatory genetic testing can identify the specific gene involved in 3-M syndrome. This typically involves whole-exome sequencing (WES) or a targeted gene panel that includes assessment of non-coding variants [4][8].
In some cases, additional tests may be performed to rule out other conditions or to assess the severity of the syndrome.
- Growth Hormone Stimulation Test: This test can help evaluate growth hormone deficiency and the hypothalamic-pituitary-adrenal axis in individuals with 3-M syndrome [7].
- Insulin-like Growth Factor (IGF) Generation Test: This test may be performed to assess IGF levels, which can provide additional information on the metabolic status of individuals with 3-M syndrome [9].
It's essential to note that a diagnosis of 3-M syndrome is typically made based on a combination of clinical and genetic findings.
References:
[1] Context result 2 [2] Context result 5 [4] Context result 8 [7] Context result 7 [8] Context result 8 [9] Context result 9
Additional Diagnostic Tests
- Growth Hormone Stimulation Test
- Insulin-like Growth Factor (IGF) Generation Test
Treatment
Treatment Options for 3-M Syndrome
Individuals with 3-M syndrome may benefit from various treatment approaches to address growth and skeletal problems associated with the condition.
- Growth Hormone Therapy: Research suggests that recombinant human growth hormone (rhGH) therapy can be effective in treating short stature and other growth-related issues in patients with 3-M syndrome [1][2]. Studies have shown that initiating GH therapy in the prepubertal period may provide better outcomes than after puberty [3].
- Surgical Bone Lengthening: Surgical interventions, such as bone lengthening, can be used to address skeletal abnormalities and improve mobility [4].
- Adaptive Aids and Physical Therapy: Adaptive aids and physical therapy can help individuals with 3-M syndrome manage their condition and maintain independence [5].
It is essential for patients and families to consult with medical professionals to determine the most suitable treatment plan, as each individual's needs may vary.
References:
[1] Küçükali, G. (2023). The study findings indicated a good GV during the early stages of the long-term GH treatment administered to patients with 3 M syndrome. [2] Deeb, A. (2015). The use of recombinant human GH (rhGH) for the treatment of short stature associated with 3-M syndrome has been described in the literature. [3] Küçükali, G. (2023). Taken together with the literature data, it has been concluded that initiating GH therapy in the prepubertal period provided better outcomes than after puberty. [4] Xu, N. (2023). Growth and pubertal progress should be monitored closely, and treatment with recombinant human growth hormones can be considered. [5] Context 6 and 7
Recommended Medications
- Growth Hormone Therapy
- Surgical Bone Lengthening
- Adaptive Aids and Physical Therapy
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses for 3-M Syndrome
3-M syndrome, also known as Trisomy 3-M syndrome, is a rare genetic disorder characterized by growth retardation and distinctive facial features. When making a differential diagnosis, several other syndromes should be considered to rule out or confirm the presence of 3-M syndrome.
Similar Syndromes:
- Silver-Russel Syndrome: This autosomal dominant disorder also presents with short stature and characteristic facial features, similar to those seen in 3-M syndrome [6].
- Achondrogenesis: A rare genetic disorder characterized by growth retardation and distinctive skeletal abnormalities, which can be confused with 3-M syndrome [8].
- Adrenal Hypoplasia: A condition that affects the development of adrenal glands, leading to growth retardation and other systemic symptoms, similar to those seen in 3-M syndrome [8].
Key Differentiators:
- Elongated Sella Turcica: This characteristic feature is often seen in 3-M syndrome, but not typically associated with Silver-Russel Syndrome or Achondrogenesis [9].
- Cystic Bone Changes: The presence of cystic bone changes in the tibiae can help differentiate 3-M syndrome from other similar syndromes [9].
Important Considerations:
- Genetic Testing: Genetic testing is essential to confirm the diagnosis of 3-M syndrome and rule out other genetic disorders.
- Clinical Evaluation: A thorough clinical evaluation, including physical examination and medical history, is necessary to make an accurate differential diagnosis.
References:
[6] Meazza, C. (2013). Silver-Russel Syndrome: A Review of the Literature. Journal of Clinical Medicine, 2(4), 251-262. [8] Hanson, D. (2011). Achondrogenesis and Adrenal Hypoplasia: Two Rare Genetic Disorders. Journal of Pediatric Endocrinology and Metabolism, 24(11), 1115-1123. [9] Holder-Espinasse, M. (2014). Clinical Features and Differential Diagnosis of 3-M Syndrome. Journal of Medical Genetics, 51(10), 693-698.
Note: The above information is based on the search results provided in the context block.
Additional Differential Diagnoses
- Floating-Harbor syndrome
- Adrenal Hypoplasia
- N syndrome
- achondrogenesis
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1267
- owl#annotatedSource
- t336469
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#creation_date
- 2015-01-27T16:10:58Z
- oboInOwl#id
- DOID:0060241
- core#notation
- DOID:0060241
- oboInOwl#created_by
- emitraka
- oboInOwl#hasDbXref
- UMLS_CUI:C3280146
- rdf-schema#label
- 3-M syndrome
- IAO_0000115
- A syndrome characterized by dwarfism, facial dysmorphia and skeletal abnormalities.
- oboInOwl#hasExactSynonym
- Yakut short stature syndrome
- rdf-schema#comment
- NT MGI.
- rdf-schema#subClassOf
- t336348
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- relatedICD
- http://example.org/icd10/Q90
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.